CD8A and cholangiocarcinoma: Although both CD8+ T cells and NK cells exhibit in vitro cytotoxicity against CCA cells, evidence for their efficacy in vivo remains limited, despite FDA approval of adoptive cell therapies for other malignancies such as melanoma.131